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Exome Sequencing Reveals Mutations in TRPV3
as a Cause of Olmsted Syndrome
Zhimiao Lin,1,7 Quan Chen,1,7 Mingyang Lee,1,7 Xu Cao,2,7 Jie Zhang,1 Donglai Ma,3 Long Chen,4
Xiaoping Hu,5 Huijun Wang,1 Xiaowen Wang,1 Peng Zhang,6 Xuanzhu Liu,6 Liping Guan,6
Yiquan Tang,2 Haizhen Yang,1 Ping Tu,1 Dingfang Bu,1 Xuejun Zhu,1 KeWei Wang,2 Ruoyu Li,1,*
and Yong Yang1,*
Olmsted syndrome (OS) is a rare congenital disorder characterized by palmoplantar and periorificial keratoderma, alopecia inmost cases,
and severe itching. The genetic basis for OS remained unidentified. Using whole-exome sequencing of case-parents trios, we have iden-
tified a de novo missense mutation in TRPV3 that produces p.Gly573Ser in an individual with OS. Nucleotide sequencing of five addi-
tional affected individuals also revealedmissensemutations in TRPV3 (which produced p.Gly573Ser in three cases and p.Gly573Cys and
p.Trp692Gly in one case each). Encoding a transient receptor potential vanilloid-3 cation channel, TRPV3 is primarily expressed in the
skin, hair follicles, brain, and spinal cord. In transfected HEK293 cells expressing TRPV3mutants, much larger inward currents were re-
corded, probably because of the constitutive opening of themutants. These gain-of-functionmutations might lead to elevated apoptosis
of keratinocytes and consequent skin hyperkeratosis in the affected individuals. Our findings suggest that TRPV3 plays essential roles in
skin keratinization, hair growth, and possibly itching sensation in humans and selectively targeting TRPV3 could provide therapeutic
potential for keratinization or itching-related skin disorders.Olmsted syndrome (OS) is a rare congenital disorder
characterized by bilateral mutilating palmoplantar kerato-
derma (PPK) and periorificial keratotic plaques with severe
itching at all lesions.1,2 Diffused alopecia, constriction of
digits, and onychodystrophy have also been reported.2
Infections and squamous cell carcinomas can arise on the
keratotic areas.3 The diagnosis of OS is based on its charac-
teristic clinical picture without any specific biologic
markers or histopathological patterns. It should be differ-
entiated from several genodermatoses, such as Vohwinkel
syndrome (MIM 124500) and acrodermatitis enteropathica
(MIM 201100).2 Until recently, only 46 individuals with
OS had been reported,4,5 including 36 sporadic cases and
four families containing ten affected individuals. The
definite mode of inheritance was still uncertain, and auto-
somal-dominant,6 X-linked-dominant7 and X-linked-
recessive8 modes of inheritance had been proposed.
Treatment of OS includes surgical removal of keratotic
palmoplantar mass and oral retinoids. However, the relief
is often temporary with a high rate of recurrence.2 No
pathogenic mutations in any of the four genes (KRT1
[MIM 139350], GJB2 [MIM 121011], SLURP1 [MIM
606119], LOR [MIM 152445]), which were previously
implicated in the pathogenesis of several hereditary
diseases with mutilating PPK, were identified in a single
individual with OS.2 Here, we demonstrate that gain-of-
function mutations within TRPV3 (MIM 607066) on chro-
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the OS phenotype.
We investigated six cases of OS in China (Table 1, Fig-
ures 1A–1C, and Figure S1, available online). Our study
was approved by the Clinical Research Ethics Committee
of Peking University First Hospital, Beijing China (institu-
tional review board number 2011[360]). Informed consent
was obtained following the rules from the institutional
review board. All the cases are sporadic except for indi-
vidual 3, whose affected daughter died of infection at
2 years; no DNA sample from the daughter was available
(Figure 1F). In all affected individuals the symptoms devel-
oped in the first year of life. Keratotic lesions were
yellowish brown and had a sharp erythematous border.
Periorificial keratotic plaques were present around the
mouth, nostrils, ear meatus, anus, and perigenital region.
They might appear to be mild and restricted or extend to
involve neck, upper thorax, lower abdomen, inguinal
folds, and upper inner thighs. PPK aggravated gradually
to become mutilating, including flexion deformity of the
fingers, constriction of the digits, that is pseudoainhum,
and even spontaneous amputation of the digits or the
hands in the severely affected individuals. Painful fissures
on the soles interfered with walking in most of the affected
individuals. Hair involvement varied, ranging from
alopecia universalis with follicular papules tomerely sparse
curly hair. All individuals complained of severe itching in
the lesions, resulting in frequent scratching and sleep4, China; 2Department of Neurobiology, Neuroscience Research Institute,
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Table 1. Phenotypic Characteristics and Amino Acid Changes in TRPV3 in Subjects with OS







1 9 female  þþþ, CDB þþþþ þþþþ Gly573Ser
2 14 female  þþ þþ þþþ Gly573Cys
3 25 female þ þþþþ, SDA þþþþ þþþþ Gly573Ser
4 12 female  þþþþ, CDB, SDA þþþ þþþ Gly573Ser
5 23 male  þþþ, CDB þþþ þþ Trp692Gly
6 27 female  þþ, CDB þþ þ (dry curly hair) Gly573Ser
The following abbreviations are used: CDB, Constricting digit bands; SDA, Spontaneous digit amputation. The following symbols are used: , absent; þ, present;
þþ, mild; þþþ, moderate; þþþþ, severe.disturbances. Thermosensation was normal in all individ-
uals, even on affected areas. No additional neurologic or
sensory anomalies were detected. No atopic history was
reported, and the serum zinc level was within normal
range in all the individuals. Consanguinity was denied in
all the families. Individuals 1, 2, and 6 were treated with
oral acitretin. Significant improvement in skin lesions
and itching sensation were noted in the three individuals
after 4 weeks, though changes in hair growth seemed
limited after 1 year of treatment. The histopathological
findings of skin biopsies from keratotic lesions of individ-
uals 1, 2, and 6 demonstrated psoriasiform hyperplasia,
orthohyperkeratosis, and parakeratosis with profound
mast cell infiltration in the upper dermis (Figures 1D and
1E). Hair follicles from nonpalmoplantar skin biopsy
were not examined in this study.
On the basis of the familial case (individual 3) we
enrolled and previous reports,6,7,9 an autosomal-dominant
trait of OS was postulated. In this way, a sporadic case was
supposed to carry a de novo pathogenic heterozygous
mutation in the causative gene. We then applied a
genome-wide approach and sequenced the exomes of
individual 1 and her parents (Beijing Genomic Institute,
Shenzhen, China). Exome capture was carried out with
SureSelect Human All Exon Kit (Agilent, Santa Clara, CA,
USA), guided by the manufacturer’s protocols and then
sequenced by Hiseq2000 platform (Illumina, San Diego,
CA, USA). We obtained about 2.4 to 3.7 Gb of mappable
sequence data per sample. Single-nucleotide variations of
individual 1 were filtered by dbSNP131, the 1000 Genomes
Project, and HapMap8 databases. To detect de novo varia-
tions, we further filtered out heterozygous variations from
her parents. Forty-five apparent de novo damaging varia-
tions were found in the individual through SIFT soft-
ware10 prediction. Given that the expected rarity of true
de novo events in the targeted exome is less than one per
trio,11 we sequenced all of these candidate variations by
using Sanger sequencing. Only one de novo heterozygous
point mutation, c.1717G>A in TRPV3, was identified in
individual 1 (Table S1). This transition substitution causes
an amino acid alteration of p.Gly573Ser (Figure 2A). We
then screened the coding exons and their flanking intronThe Amesequences (primers are listed in Table S2) in TRPV3 in the
five additional individuals and found heterozygous mis-
sense mutations in all of them (Table 1 and Figure 2A).
No same variations were found in the parents of individ-
uals 2, 4, 5, and 6, indicating that they are de novo muta-
tions. The mother of individual 3 passed away, so the
origin of themutation in individual 3 cannot be identified.
We also sequenced these sites in TRPV3 in 216 ethnically
matched normal controls, and these three mutations
were not detected.
Because TRPV3 is a transmembrane ion channel protein,
we further investigated the electrophysiological effect of
TRPV3 mutations via the patch-clamp technique. cDNA
clones of the whole coding region of human TRPV3 in
the pCMV6-AC-GFP vector was obtained from Origene
(Rockville, MD). With this plasmid as the template, site-
directed mutagenesis (Fast Mutagenesis System, Transgen
Biotech, Beijing, China) was performed to obtain three
clones containing the point mutations found in the indi-
viduals with OS (the primers used are listed in Table S3).
HEK293 cells were transiently transfected with plasmids
expressing wild-type (WT), p.Gly573Ser, p.Gly573Cys, or
p.Trp692Gly TRPV3 proteins with 1 ml lipofectamine
2000 (Invitrogen). After 24 hr of transfection, HEK293 cells
with green fluorescence located primarily in the cellular
membrane were chosen for patch-clamp recordings under
an inverted fluorescence microscope (IX71, Olympus, To-
kyo, Japan). Both whole-cell and inside-out patch were
performed with an EPC10 amplifier (HEKA, Lambrecht,
Germany) driven by PatchMaster software (HEKA). Both
bath and pipette solutions contained 130 mM NaCl,
3 mM HEPES, and 0.3 mM EGTA (pH 7.4). All measure-
ments were carried out at room temperature (22–25C).
We evaluated the voltage-dependent properties for each
mutant. After breaking into the whole-cell configuration,
we found that patches from the HEK293 cells expressing
p.Gly573Ser, p.Gly573Cys, or p.Trp692Gly TRPV3 altered
channels were leaky and showed large inward leakage-
like currents with almost linear current-voltage relation-
ship and secondary conducting phase of TRPV3
current.12 This indicates that themutant channels are fully
open (Figures 3A–3D). To rule out the possibility that theserican Journal of Human Genetics 90, 558–564, March 9, 2012 559
Figure 1. Phenotypic Characteristics of OS
(A) Bilateral mutilating palmoplantar keratoderma, flexion deformities and constriction of digits in individual 1.
(B) Keratotic plaques involving periorificial, neck and axillary areas in individual 1.
(C) Diffused alopecia with follicular papules in individual 2.
(D) Skin biopsy section demonstrating psoriasiform hyperplasia, orthohyperkeratosis and parakeratosis in individual 1 (hematoxylin-
eosin staining; the scale bar represents 100 mm).
(E) Individual 1, skin biopsy section showing profoundmast cell infiltration in upper dermis (toluidine blue staining; the scale bar repre-
sents 100 mm).
(F) The pedigree of individual 3 (arrow indicates individual 3).large currents were caused by leakage due to poor cell
conditions, we evaluated these mutants by inside-out
patch recordings. It is notable that all the threemutants ex-
hibited fast inactivation currents at a more depolarization
potential (þ220 mV) (Figure S2). For outwardly rectifying
WT TRPV3 channels, the inactivation can only be
observed when the channels are fully activated by satu-
rating concentrations of ligands,13,14 indicating these
mutants resembling an overactive WT TRPV3 channel.
To further test the pharmacology of the mutants in
response to ligand stimulation, we determined agonist-
evoked currents from inside-out patches by applying
300 mM 2-aminoethoxydiphenyl borate (2-APB), and
nonspecific leak currents were assessed by superfusing
Ba2þ from intracellular side to completely block TRPV3
currents.15 Unlike WT TRPV3, the saturating concentra-
tions of 2-APB had no significant effects on or even
partially inhibited the basal currents from the cells express-
ing the mutant channels (Figures 3E–3H). Indeed, 2-APB
not only activated TRPV3 but also slightly inhibited the
channel activity when the channel was fully open.14,16
Collectively, our data indicate that p.Gly573Ser,
p.Gly573Cys, and p.Trp692Gly TRPV3 are constitutively
active and act in a gain-of-function manner. Similarly, in
a previous study that used Xenopus oocytes expressing
murine p.Gly573Ser or p.Gly573Cys, larger basal currents
and lower temperature thresholds were observed.17
Because activation of TRPV3 was previously shown to
induce apoptosis,18 we next evaluated whether these560 The American Journal of Human Genetics 90, 558–564, March 9gain-of-function mutations in TRPV3 could lead to
increased cell death of transfected HEK293 cells and kerati-
nocytes in our individuals. Transfected HEK293 cells
(detailed above) were cultured for 24 hr and then stained
by Hoechst 33342 and propidium iodide (PI) for 15 min
before morphological cell death assessment. Cells were
observed by inverted fluorescence microscope (IX71,
Olympus, Japan) with UV/488 nm dual excitation. Dead
cells, shown as PI positive, were counted in five randomly
selected high-power fields (4003, more than 1,000 cells
total per specimen) with an ImageJ cell counter. Three
independent experiments were conducted. For statistical
analyses, the experimental data were analyzed by one-
way analysis of variance (ANOVA). Comparison of mutant
groups with the WT group was carried out by Fisher’s least
significant difference (LSD) test. Compared to WT, cells
expressing the mutant TRPV3 tended to result in a signifi-
cantly higher cell death rate at 24 hr after transfection
(Figures 4A and 4B). The cell death could be partly rescued
by a TRP channel inhibitor ruthenium red (Figure S3).
In situ apoptosis examination of the keratinocytes
in keratotic lesions in individuals 1, 2, and 6 was con-
ducted with the TUNEL method (In Situ Cell Death Detec-
tion Kit, Roche). Skin sections from the normal edge of
surgically excised palm pigmented nevus in three
unrelated healthy subjects were used as the controls.
Images above the basal layer of the epidermis were taken
randomly with a fluorescence microscope with the same
photograph parameters. Total cells and apoptotic cells, 2012
Figure 2. Mutations and Schematic Structure
of TRPV3
(A)Sequencing results demonstrating heterozy-
gous TRPV3 mutation of c.1717G>A (amino
acid change of p.Gly573Ser) in individuals 1, 3,
4, and 6; c.1717G>T (p.Gly573Cys) in individual
2; and c.2074T>G (p.Trp692Gly) in individual 5.
(B) Schematic structure of TRPV3 protein and
multiple alignment of the linker region between
S4 and S5 and the TRP domain, with the align-
ments of corresponding segments of human
TRPV1-2 and 4-6 proteins. Gly573 and Trp692
are highly conserved residues. The mutation sites
that produce p.Gly573Ser (M1), p.Gly573Cys
(M2), and p.Trp692Gly (M3) are also aligned
with the substitution positions (black high-
lighted).(with fluorescent nucleus) in five random high-power
fields (4003) were counted, and the percentage of
apoptotic cells was calculated (apoptotic cells/total cells
3 100%). Apoptotic cell rates in the affected individuals
were significantly higher compared to the normal controls
(Figures 4C and 4D).
Here we performed exome sequencing in a single family
and have identified mutations in TRPV3 as one of the
genetic bases for OS. For sporadic cases of rare autosomal-
dominant Mendelian disorders, exome sequencing of
case-parents trios has proven to be a cost-effective and
promising strategy to unravel causative genes. Our find-
ings suggest OS is inherited in an autosomal-dominant
pattern. However, only a few familial cases were reported,
possibly because of the severe skin lesions. Other suggested
modes of inheritance in OS, including X-linked dominant7
and X-linked recessive,8 are probably due to genetic
heterogeneity or incomplete penetrance of this disease.
TRPV3was cloned in 2002. It belongs to a superfamily of
transient receptor potential (TRP) cation channels. It is
mainly expressed in keratinocytes, hair follicles, and the
brain and spinal cord.19–21 As a thermosensitive channel,
TRPV3 is activated at 33C, and therefore, it was supposed
to play a role in warm sensation.22 Notably, in spite of anThe American Journal of Hintolerant itching sensation, the individ-
uals in our study did not experience any
other abnormal sensation, including
thermosensation. Recent data also suggest
that TRPV3 is not a major contributor to
mouse heat sensation.23 TRPV3 is also ex-
pressed in the central nervous system, but
intriguingly, we did not observe any
obvious neurological or psychiatric clinical
symptoms other than itching in anyone
of the individuals we studied. However,
we cannot rule out the possibility that
some related clinical manifestations were
very subtle. Activation of TRPV3 can ele-
vate intracellular Ca2þ concentration,
induce apoptosis, and inhibit humanhair growth,18 which explains the manifestation of
alopecia in these individuals. Recent studies also show
that TRPV3 is a Ca2þ entry pathway tightly associated
with the TGF-a/EGFR signaling complex orchestrating
keratinocyte terminal differentiation.24 TRPV3 knockout
mice present abnormal hair morphology and skin barrier
function.25 Spontaneous mutant rodent strains, DS-Nh
mice (carrying the TRPV3 mutation that produces
p.Gly573Ser) and WBN/Kob-Ht rats (carrying the TRPV3
mutation that produces p.Gly573Cys), exhibit hairlessness
and dermatitis.26 However, it is still poorly understood
how TRPV3 functions in the keratinization of the skin in
humans.
Alignment of the TRPV paralogs demonstrates that
Gly573 and Trp692, the amino acids that we find
altered in the six individuals in this study, have been
completely conserved in this region of the protein.
(Figure 2B). Notably, all the female individuals we
studied carry mutations located in the site that produces
Gly573. Individual 5, carrying p.Trp692Gly, has less
severe alopecia (Figure S1). Individual 5 is a male, and
whether male gender and/or the characteristic mutation
relate to his mild hair involvement is yet unknown.
Because of the limited number of cases reported here,uman Genetics 90, 558–564, March 9, 2012 561
Figure 3. Whole-Cell and Inside-Out Recordings of TRPV3 Currents from Transfected HEK293 Cells
(A–D) Representative whole-cell current traces in HEK293 cells expressing TRPV3 or mutant channels in response to the voltage step
protocol (left panels), and respective current-voltage plots from the steady-state currents (right panels).
(E–H) Representative currents from inside-out patches in HEK293 cells expressing TRPV3 or mutant channels in response to stimulation
by 300 mM 2-APB or inhibition by 130 mM Ba2þ to assess the level of leak currents, at 80 mV and þ80 mV. WT TRPV3 current is acti-
vated by 2-APB and followed by a characteristic decay. Note that the mutants Gly573Ser, Gly573Cys, and Trp692Gly show little activa-
tion, then inhibition in the presence of 2-APB, and a robust block by Ba2þ.
(I) Comparison of ratios of currents evoked by 2-APB (300 mM) over basal currents between the TRPV3WTand mutant channels. (t test,
n ¼ 3–7. p ¼ 0.00001).
Error bars represent SEM.the genotype-phenotype correlation of OS remains to be
defined. Interestingly, spontaneous mutant rodent strains
DS-Nh mice and WBN/Kob-Ht rats carry p.Gly573Ser and
p.Gly573Cys, respectively, identical to the altered
proteins in individuals 1, 2, 3, 4, and 6. These mutant
rodents develop the phenotype of whole-body hairless
and pruritic dermatitis on their faces without keratosis
on their paws. They were considered as an animal model
of atopic dermatitis.26 Although all the individuals denied
a history of atopy, the itching was obvious in the skin
lesions.
TRPV3 channel contains six transmembrane domains
with a pore region between the fifth (S5) and sixth (S6)562 The American Journal of Human Genetics 90, 558–564, March 9segments, and both C and N termini are intracellularly
located (Figure 2B). The two sites we detected, which
produce Gly573 and Trp692, are located in the linker
region between S4 and S5 and in the TRP box (amino
acid sequence of IWRLQR) of TRP domain (Figure 2B),
respectively. Based on the high-resolution structure of
voltage-gated potassium channel Kv1.2, the movement
of the S4 voltage sensor is coupled to pore opening via
interactions between residues in the S4-S5 linker and the
C-terminal end of S6.27 If the TRPV channels share a similar
architecture with the Kv1.2 channel, then the TRP domain
is located at the C-terminal immediately after S6, poten-
tially placing it in proximity to the S4-S5 linker. We, 2012
Figure 4. Cell Death of Transfected HEK293 Cells and Apoptosis of Affected Individuals’ Keratinocytes
(A) Merged images of transfected HEK293 cells stained with PI (red) and Hoechst 33342 (blue). Mutants show significantly more PI-posi-
tive cells compared to wild-type TRPV3.
(B) Quantification of cell death rates in transfected HEK293 cells (red nuclei/blue nuclei3 100%). Data are averaged from three indepen-
dent experiments. *p < 0.05, **p < 0.01.
(C) Fluorescence microscope images (TUNEL method) of palm skin biopsy sections from an unrelated control, individuals 1, 2, and 6.
Large amount of apoptotic cells (with fluorescent nuclei) are seen in individuals with OS. The scale bars represent 50 mm.
(D) Quantification of apoptotic keratinocytes in the skin sections. The mean proportion of apoptotic cells are significantly higher in the
group of OS patients than in the group of normal controls (t test, n ¼ 3, p ¼ 0.000005).
Error bars represent SEM.proposed that similar to voltage-gated potassium chan-
nels,28–30 the S4-S5 linker of TRPV channel might interact
with the TRP domain to maintain the channel in closed
state, and contributes to transferring activating mechan-
ical energy to open the intracellular S6 gate. Therefore,
the mutations we detected could disrupt the coupling
and lock the channel in the open conformation.
Ion channels serve many functions, including the trans-
port of ions and water, the control of electrical excitability,
and the regulation of ionic homeostasis. Proliferation and
differentiation of keratinocytes and hair follicles, as well as
sensation of pain and itching, are precisely controlled by
ionic signals. So far, several kinds of channelopathies
mainly involved in skin have been identified. Gap junc-
tion proteins, such as GJB2, GJB3, GJB4 and GJB6, are
defective in several kinds of keratoderma. Alterations in
voltage-gated sodium channel type IX alpha subunit are
responsible for primary erythromelalgia (MIM 133020),
an autosomal-dominant disorder characterized by burning
pain and skin redness in extremities.31 Here, we show
a skin channelopathy caused by TRPV3 mutations. The
mutant TRPV3 might function in a dominant-positive
manner to increase the constitutive TRPV3 activity and
elevate Ca2þ in keratinocytes, leading to severe kerato-
derma and intolerant itching sensation. The nature of
the mutations we described here also indicates that modu-
lation of TRPV3 activity could be an alternative approachThe Ameto the treatment of skin keratinization, hair, and itching
disorders.Supplemental Data
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